查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
結直腸癌篩查市場,通過篩查測試（糞便測試,結腸鏡檢查,CT結腸造影,柔性乙狀結腸鏡檢查,其他）,用戶,地區-大小,份額,前景,機會分析2022-2028
市場調查報告書
商品編碼
1110146

結直腸癌篩查市場,通過篩查測試（糞便測試,結腸鏡檢查,CT結腸造影,柔性乙狀結腸鏡檢查,其他）,用戶,地區-大小,份額,前景,機會分析2022-2028

Colorectal Cancer Screening Market, By Screening Tests (Stool-based Tests, Colonoscopy, CT Colonography, Flexible Sigmoidoscopy, and Other Screening Tests), By End User, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
出版日期: | 出版商: Coherent Market Insights | 英文 181 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

結直腸癌是一種在大腸（結腸）中形成的癌症。癌症也稱為結腸癌或直腸癌，這取決於它從哪裡開始。結直腸癌篩查很重要，因為如果及早發現結直腸癌是高度可治療的。在結直腸癌的早期階段，通常沒有任何症狀。定期篩查可降低結直腸癌死亡和並發症的風險。篩查有助於在症狀出現之前及早發現癌症。如果在局部階段診斷出癌症，存活率將達到 90%。如果癌症已經擴散到附近的組織、器官或區域淋巴結，5 年生存率為 73%。如果癌症擴散到遠處，5年生存率為17%。

市場動態:

預計結直腸癌患病率的上升、癌症預防工作的加強以及公眾對結直腸癌篩查的認識將有助於全球結直腸癌篩查市場在預測期內增長。是一些主要因素例如，結腸癌是一種致命的疾病，在沒有積極篩查的情況下，它的早期階段往往無法識別或未被診斷。篩查是檢測結直腸癌的首要方法，並且幾乎總是 100% 由大多數保險計劃承保。 2021 年，美國政府宣布 3 月為“全國結直腸癌宣傳月”，以提高對結直腸癌管理的認識，引起人們對結直腸癌這一美國第三大最常見癌症的關注。

本研究的主要特點

  • 本報告對全球結直腸癌篩查市場進行了深入分析，提供了以 2021 年為基準年的預測期（2022-2028 年）的市場規模和復合年增長率 (CAGR %)。
  • 它揭示了不同細分市場的潛在收入機會，並為該市場概述了一個有吸引力的投資建議矩陣。
  • 它還提供有關市場驅動因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景、主要參與者採用的競爭策略等方面的重要見解。
  • 全球結直腸癌篩查市場主要參與者的概況基於以下參數，包括公司亮點、產品組合、關鍵亮點、業績和戰略。
  • 本研究涵蓋的主要公司包括 Polymedco Inc.、Eiken Chemical Co. Ltd.、Sysmex Corporation、Siemens Healthineers、Quidel Corporation、Novigenix SA、Hemosure Inc.、Exact Sciences Corp.、Epigenomics Inc.、Olympus Corporation和臨床基因組學技術私人有限公司等。
  • 本報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
  • 全球結直腸癌篩查市場報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和財務分析師。
  • 利益相關者可以通過用於分析全球結直腸癌篩查市場的各種戰略矩陣來促進決策制定。

第一章研究目標和先決條件

  • 調查目的
  • 先決條件
  • 縮寫說明

第二章市場展望

  • 舉報內容
    • 市場定義和範圍
  • 執行摘要
    • 鼻給藥模式市場:通過篩選測試
    • 鼻腔給藥模式市場:按最終用戶分類
    • 按地區分列的鼻腔給藥模式市場
  • 連貫的機會圖 (COM)

第 3 章市場動態、監管和趨勢分析

  • 市場動態
    • 全球結直腸癌患病率不斷上升
    • 篩選費用高
    • 有效篩查測試的出現
  • 影響分析
  • 主要亮點
  • 監管場景
  • 產品發布/批准
  • PEST 分析
  • PORTER 分析
  • 併購方案

第 4 章結直腸癌篩查市場 - 冠狀病毒 (COVID-19) 大流行的影響

  • COVID-19 的流行病學
  • 供應方和需求方分析
  • 經濟影響

第 5 章結直腸癌篩查市場，按篩查測試，2017-2028 年

  • 基於糞便的測試
  • 結腸鏡檢查
  • CT 結腸成像（虛擬結腸鏡檢查）
  • 柔性乙狀結腸鏡檢查
  • 其他篩查測試

第 6 章結直腸癌篩查市場，按最終用戶，2017-2028 年

  • 醫院獨立診斷實驗室
  • 其他最終用戶

第 7 章結直腸癌篩查市場 2017-2028 年各地區結直腸癌篩查市場

  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲
  • 世界其他地區

第 8 章競爭格局

  • Polymedco Inc.
  • Eiken Chemical Co. Ltd.
  • Sysmex Corporation
  • Siemens Healthineers AG
  • Quidel Corporation
  • Novigenix SA
  • Hemosure Inc.
  • Exact Sciences Corp.
  • Epigenomics Inc.
  • Olympus Corporation
  • Clinical Genomics Technologies Pty Ltd.

第九章章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI5098

Colorectal cancer is a type of cancer that begins in the large intestine (colon). The cancer can also be called colon cancer or rectal cancer, depending on where they start. Colorectal cancer screening is important because when found early, colorectal cancer is highly treatable. Early stages of colorectal cancer usually present no symptoms. Regular screenings may reduce the risk for death and complications caused by colorectal cancer. Screening help find cancer at an early stage, before symptoms appear. If the cancer is diagnosed at a localized stage, the survival rate is 90%. If the cancer spread to surrounding tissues or organs and/or the regional lymph nodes, the 5-year survival rate is 73%. If the cancer has spread to distant parts of the body, the 5-year survival rate is 17%.

Market Dynamics:

Increasing prevalence of colorectal cancer, increasing cancer prevention initiatives, and rise in awareness among people about colorectal cancer screening are some major factors expected to aid in the growth of the global colorectal cancer screening market during the forecast period. For instance, colorectal cancer can be a deadly disease, but without proactive screenings, it's one that often goes unnoticed or undiagnosed in its early stages. Screenings are the No. 1 way to detect colorectal cancers and in most cases are covered 100% by most insurance plans. The US government, in 2021, declared March as the National Colorectal Cancer Awareness Month to increase awareness on colorectal cancer management, bringing attention to colorectal cancer, the third most commonly diagnosed cancer in the U.S.

Key features of the study:

  • This report provides in-depth analysis of the global colorectal cancer screening market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global colorectal cancer screening market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Polymedco Inc., Eiken Chemical Co. Ltd., Sysmex Corporation, Siemens Healthineers, Quidel Corporation, Novigenix SA, Hemosure Inc., Exact Sciences Corp., Epigenomics Inc., Olympus Corporation, and Clinical Genomics Technologies Pty Ltd., among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global colorectal cancer screening market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global colorectal cancer screening market.

Detailed Segmentation:

Global Colorectal Cancer Screening Market, By Screening Tests:

  • Stool-based Tests
  • Colonoscopy
  • CT Colonography (Virtual Colonoscopy)
  • Flexible Sigmoidoscopy
  • Other Screening Tests

Global Colorectal Cancer Screening Market, By End User:

  • Hospitals Independent Diagnostic Labs
  • Other End Users

Global Colorectal Cancer Screening Market, By Geography:

  • North America
  • South America
  • Europe
  • Asia-Pacific
  • Middle East & Africa

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Colorectal Cancer Screening, By Screening Tests
    • Market Colorectal Cancer Screening, By End User
    • Market Colorectal Cancer Screening, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increase in prevalence of colorectal cancer worldwide
    • High Screening Tests Costs
    • Advent of efficacious screening tests
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Colorectal Cancer Screening Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Colorectal Cancer Screening Market, By Screening Tests, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Stool-based Tests
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Colonoscopy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • CT Colonography (Virtual Colonoscopy)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Flexible Sigmoidoscopy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Other Screening Tests
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

6. Colorectal Cancer Screening Market, By End User, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Hospitals Independent Diagnostic Labs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Other End Users
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

7. Colorectal Cancer Screening Market, By Geography, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Middle East and Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Rest of World
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)

8. Competitive Landscape

  • Polymedco Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Eiken Chemical Co. Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sysmex Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Siemens Healthineers AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Quidel Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novigenix SA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hemosure Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Exact Sciences Corp.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Epigenomics Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Olympus Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Clinical Genomics Technologies Pty Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us